These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27524468)

  • 1. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.
    Mahmoudpour SH; Baranova EV; Souverein PC; Asselbergs FW; de Boer A; Maitland-van der Zee AH;
    Br J Clin Pharmacol; 2016 Dec; 82(6):1647-1659. PubMed ID: 27524468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.
    Dubrall D; Schmid M; Stingl JC; Sachs B
    PLoS One; 2020; 15(3):e0230632. PubMed ID: 32214375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitor-mediated angioedema.
    Montinaro V; Cicardi M
    Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
    Maroteau C; Siddiqui MK; Veluchamy A; Carr F; White M; Cassidy AJ; Baranova EV; Rasmussen ER; Eriksson N; Bloch KM; Brown NJ; Bygum A; Hallberg P; Karawajczyk M; Magnusson PKE; Yue QY; Syvänen AC; von Buchwald C; Alfirevic A; Maitland-van der Zee AH; Wadelius M; Palmer CNA;
    Clin Pharmacol Ther; 2020 Dec; 108(6):1195-1202. PubMed ID: 32496628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
    Schlienger RG; Korn JR; Wehler E; Lopez Leon S; Yeaw J
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):465-474. PubMed ID: 28779444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
    Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
    BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA.
    Do TP; Seetasith A; Belleli R; Schlienger RG; Corda S; Burudpakdee C; Streefkerk HJ; Behr S
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):205-211. PubMed ID: 29177815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study.
    Rasmussen ER; Pottegård A; Bygum A; von Buchwald C; Homøe P; Hallas J
    J Intern Med; 2019 May; 285(5):553-561. PubMed ID: 30618189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitor use and risk of cataract: a case-control analysis.
    Becker C; Jick SS; Meier CR
    Br J Ophthalmol; 2019 Nov; 103(11):1561-1565. PubMed ID: 30733210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
    Reichman ME; Wernecke M; Graham DJ; Liao J; Yap J; Chillarige Y; Southworth MR; Keeton S; Goulding MR; Mott K; Kelman JA
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1190-1196. PubMed ID: 28722207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.
    Mahmoudpour SH; Asselbergs FW; Souverein PC; de Boer A; Maitland-van der Zee AH
    Br J Clin Pharmacol; 2018 Oct; 84(10):2365-2372. PubMed ID: 29943849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
    Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
    BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors as a cause of isolated angioedema in a Slovenian population.
    Zupanc C; Košnik M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):1-4. PubMed ID: 27014771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema and Cough.
    Hallberg P; Nagy J; Karawajczyk M; Nordang L; Islander G; Norling P; Johansson HE; Kämpe M; Hugosson S; Yue QY; Wadelius M
    Ann Pharmacother; 2017 Apr; 51(4):293-300. PubMed ID: 27889699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors.
    Mahmoudpour SH; Asselbergs FW; de Keyser CE; Souverein PC; Hofman A; Stricker BH; de Boer A; Maitland-van der Zee AH
    Int J Clin Pharm; 2015 Dec; 37(6):1095-103. PubMed ID: 26159317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
    Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
    Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.
    Alharbi FF; Kholod AAV; Souverein PC; Meyboom RH; de Groot MCH; de Boer A; Klungel OH
    Fundam Clin Pharmacol; 2017 Dec; 31(6):676-684. PubMed ID: 28767167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.